MedTrace Logo

HIV Disclosure and Medication Adherence, a Pilot Study

NCT01621412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2015-12-22

No results posted yet for this study

Summary

The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.

Conditions

  • HIV Infection

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • Swiss HIV Cohort Study

    collaborator NETWORK

  • Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

    lead OTHER

Principal Investigators

  • Marie-Paule Schneider, PhD · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

  • Aurélie Gertsch, PhD-Student · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

  • Olivier Bugnon, Professor · Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

  • Matthias Cavassini, MD · Centre Hospitalier Universitaire Vaudois

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01621412 on ClinicalTrials.gov